CD4 and cancer: To investigate the distribution of LOY cells in CD4 + T lymphocytes we collected three public scRNAseq datasets containing fluorescence-activated cell sorted (FACS) T lymphocytes from cancer patients, with samples taken from tumour, healthy tissue and blood [22–24].